Global Response AID
Global Response Aid (GRA) is a joint venture between Agility and Ai Pharma, focused on addressing public health challenges, particularly those arising from the COVID-19 pandemic. GRA specializes in the development and distribution of innovative pharmaceutical products, notably the antiviral Avigan (Favipiravir), which has been used extensively during the pandemic. The company differentiates itself through its partnerships with leading pharmaceutical firms and its commitment to providing effective healthcare solutions. With a global production capacity and a focus on safety and efficacy, GRA has positioned itself as a trusted provider for governments and health authorities, aiming to improve public health outcomes and respond to future health crises.
Global Response AID
Global Response Aid (GRA) is a joint venture between Agility and Ai Pharma, focused on addressing public health challenges, particularly those arising from the COVID-19 pandemic. GRA specializes in the development and distribution of innovative pharmaceutical products, notably the antiviral Avigan (Favipiravir), which has been used extensively during the pandemic. The company differentiates itself through its partnerships with leading pharmaceutical firms and its commitment to providing effective healthcare solutions. With a global production capacity and a focus on safety and efficacy, GRA has positioned itself as a trusted provider for governments and health authorities, aiming to improve public health outcomes and respond to future health crises.